ABVD
ABVD is a chemotherapy regimen used in the first-line treatment of Hodgkin lymphoma, supplanting the older MOPPprotocol. It consists of concurrent treatment with the chemotherapy drugs:
(A)driamycin (also known asdoxorubicin/(H)ydroxydaunorubicin, designated as H in CHOP)(B)leomycin(V)inblastine(D)acarbazine (similar to(P)rocarbazine, designated as P inMOPP and in COPP)
Indications
As of 2007, ABVD is widely used as the initial chemotherapy treatment for newly diagnosed Hodgkin's lymphoma[citation needed]. The other chemotherapy regimen that is widely used in this setting is the Stanford Vregimen.
No comments:
Post a Comment